DALT

DALT
Clinical data
Other namesN,N-Diallyltryptamine; DALT; DAT
Routes of
administration
Oral, intramuscular injection
Drug classSerotonin receptor modulator; Serotonergic psychedelic; Hallucinogen
ATC code
  • None
Legal status
Legal status
  • DE: NpSG (Industrial and scientific use only)
  • UK: Class A
  • US: Analogue to a Schedule I/II drug (possibly)
  • UN: Unscheduled but not approved for human consumption.
  • in theory could be covered under similar analogue bills in other countries but this is not confirmed.
Identifiers
  • N-Allyl-N-[2-(1H-indol-3-yl)ethyl]prop-2-en-1-amine
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC16H20N2
Molar mass240.350 g·mol−1
3D model (JSmol)
  • C=CCN(CC=C)CCc2c[nH]c1ccccc12
  • InChI=1S/C16H20N2/c1-3-10-18(11-4-2)12-9-14-13-17-16-8-6-5-7-15(14)16/h3-8,13,17H,1-2,9-12H2 checkY
  • Key:LQEATNFJCMVKAC-UHFFFAOYSA-N checkY
  (verify)

Diallyltryptamine (DALT), also known as N,N-diallyltryptamine, is a tryptamine derivative which has been identified as a designer drug.

Use and effects

According to Alexander Shulgin in his book TiHKAL (Tryptamines I Have Known and Loved), the dose of DALT is greater than 40 mg orally and its duration is unknown. Its effects were not described. Per Stephen Szara and colleagues in much earlier publications however, DALT and other extended N,N-dialkyltryptamines produce similar effects to dimethyltryptamine (DMT) but are longer-lasting, with durations of up to 3 hours.

Interactions

Pharmacology

Pharmacodynamics

DALT activities
TargetAffinity (Ki, nM)
5-HT1A100
5-HT1B>10,000
5-HT1D689
5-HT1E378
5-HT1FND
5-HT2A701
5-HT2B61
5-HT2C385
5-HT3>10,000
5-HT4ND
5-HT5A>10,000
5-HT61,718
5-HT7>10,000
α1A1,663
α1B1,369
α1D>10,000
α2A124
α2B305
α2C901
β1–β3>10,000
D1, D2>10,000
D3672
D4, D5>10,000
H1127
H2–H4>10,000
M1–M5>10,000
I1ND
σ1101 (rat)
σ2356 (rat)
TAAR1Tooltip Trace amine-associated receptor 1ND
MORTooltip μ-Opioid receptor, DORTooltip δ-Opioid receptor>10,000
KORTooltip κ-Opioid receptor2,477
SERTTooltip Serotonin transporter150 (Ki)
NETTooltip Norepinephrine transporter1,121 (Ki)
DATTooltip Dopamine transporter1,406 (Ki)
Notes: The smaller the value, the more avidly the drug binds to the site. All proteins are human unless otherwise specified. Refs:

The receptor interactions of DALT have been studied. The drug produces the head-twitch response, a behavioral proxy of psychedelic effects, in rodents.

Chemistry

DALT has been used as an intermediate in the preparation of radiolabeled diethyltryptamine (DET).

Synthesis

The chemical synthesis of DALT has been described.

Analogues

Analogues of DALT include 4-HO-DALT, 4-AcO-DALT, 5-MeO-DALT, methylallyltryptamine (MALT), propylallyltryptamine (PALT), and isopropylallyltryptamine (iPALT), among others.

History

DALT was first described in the scientific literature by Stephen Szara and colleagues by 1962.

Society and culture

Canada

DALT is not an explicitly nor implicitly controlled substance in Canada as of 2025.

United States

DALT is not an explicitly controlled substance in the United States. However, it could be considered a controlled substance under the Federal Analogue Act if intended for human consumption.

See also